Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.1% | −4.6% | −3.6% | −8.7% | +2.4% | −6.6% | −1.8% | −39.2% | — | −13.9% |
| Peer average | −1.5% | −5.2% | −7.0% | −17.9% | −19.0% | −19.4% | +10.9% | −30.9% | +19.2% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$99 of every $1,000 in KURE is Beone
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 6160.HKBeone Medicines | Healthcare | 9.89% | $989.18 | 342K | $10.7M |
| 2 | 1801.HKInnovent Biologics | Healthcare | 8.26% | $825.71 | 837K | $8.9M |
| 3 | 2269.HKWuxi Biologics Cayman | Healthcare | 7.28% | $728.41 | 1.4M | $7.9M |
| 4 | 603259.SSWuxi Apptec | Healthcare | 5.67% | $566.81 | 283K | $6.1M |
| 5 | 300760.SZShenzhen Mindray Bio-medic | Healthcare | 4.75% | $474.68 | 185K | $5.1M |
| 6 | 600276.SSJiangsu Hengrui Pharmaceut | Healthcare | 4.60% | $459.80 | 705K | $5.0M |
| 7 | 1177.HKSino Biopharmaceutical | Healthcare | 4.03% | $403.09 | 6.3M | $4.3M |
| 8 | 1093.HKCspc Pharmaceutical Group LT | Healthcare | 3.43% | $343.10 | 3.6M | $3.7M |
| 9 | 2359.HKWuxi Apptec -H | Healthcare | 3.26% | $325.51 | 145K | $3.5M |
| 10 | 3692.HKHansoh Pharmaceutical Group | Healthcare | 3.10% | $309.84 | 802K | $3.3M |
| 11 | 9926.HKAkeso | Healthcare | 2.91% | $291.37 | 418K | $3.1M |
| 12 | 000538.SZYunnan Baiyao Group | Healthcare | 2.65% | $265.21 | 339K | $2.9M |
| 13 | 1548.HKGenscript Biotech | Healthcare | 2.62% | $262.34 | 720K | $2.8M |
| 14 | 688271.SSShanghai United Imaging He | Healthcare | 2.55% | $254.63 | 157K | $2.7M |
| 15 | 300015.SZAier EYE Hospital Group | Healthcare | 2.24% | $223.55 | 1.8M | $2.4M |
Every fund here earned less than cash (3.8%) over the past year; the bars still rank them by return for the bumps.
of the $18.4B in 24 China ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 6160.HK | Beone Medicines | 9.89% |
| 2 | 1801.HK | Innovent Biologics | 8.26% |
| 3 | 2269.HK | Wuxi Biologics Cayman | 7.28% |
| 4 | 603259.SS | Wuxi Apptec -A | 5.67% |
| 5 | 300760.SZ | Shenzhen Mindray Bio-medic-a | 4.75% |
| 6 | 600276.SS | Jiangsu Hengrui Pharmaceut-a | 4.60% |
| 7 | 1177.HK | Sino Biopharmaceutical | 4.03% |
| 8 | 1093.HK | Cspc Pharmaceutical Group LT | 3.43% |
| 9 | 2359.HK | Wuxi Apptec -H | 3.26% |
| 10 | 3692.HK | Hansoh Pharmaceutical Group | 3.10% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 23, 2025 | $0.71 |
| Dec 17, 2024 | Dec 18, 2024 | $0.18 |
| Dec 18, 2023 | Dec 20, 2023 | $0.11 |
| Dec 28, 2022 | Dec 30, 2022 | $0.0104 |
| Dec 29, 2021 | Dec 31, 2021 | $4.05 |
| Dec 29, 2020 | Dec 31, 2020 | $0.0001 |
| Dec 27, 2019 | Dec 31, 2019 | $0.0573 |
| Dec 26, 2018 | Dec 28, 2018 | $0.0760 |